Vext Science Poised for Growth with Solid Q1 Results
Company Announcements

Vext Science Poised for Growth with Solid Q1 Results

Vext Science (TSE:VEXT) has released an update.

Vext Science reports a solid Q1 2024 with $8.4 million in revenue and $1.9 million in adjusted EBITDA, despite a challenging consumer environment. Poised for growth, Vext anticipates benefits from the upcoming adult-use program in Ohio and has secured a $2 million credit facility to support operations and seize market opportunities.

For further insights into TSE:VEXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskVext Science to Release Q3 2024 Financial Results
TipRanks Canadian Auto-Generated NewsdeskVext Science Strikes Investor Relations Deal With PartnerCap
TipRanks Canadian Auto-Generated NewsdeskVext Science Foresees Growth with Ohio’s Cannabis Program
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App